/term/ShortPercentageOfFloat/SZSE:301331 Enwei Pharmaceutical Co (SZSE:301331) Short Percentage of F
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enwei Pharmaceutical Co Ltd (SZSE:301331) » Definitions » Short Percentage of Float

Enwei Pharmaceutical Co (SZSE:301331) Short Percentage of Float


View and export this data going back to 2022. Start your Free Trial

What is Enwei Pharmaceutical Co Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of Enwei Pharmaceutical Co's Short Percentage of Float

For the Drug Manufacturers - Specialty & Generic subindustry, Enwei Pharmaceutical Co's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enwei Pharmaceutical Co's Short Percentage of Float Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Enwei Pharmaceutical Co's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Enwei Pharmaceutical Co's Short Percentage of Float falls into.



Enwei Pharmaceutical Co (SZSE:301331) Business Description

Traded in Other Exchanges
N/A
Address
Chuangye Avenue, Enwei Building, Economic Development Zone, Aba District, Tibet Autonomous Region, Changdu, CHN, 854000
Enwei Pharmaceutical Co Ltd is engaged in the research and development, production and sales of proprietary Chinese medicines and chemical medicines.

Enwei Pharmaceutical Co (SZSE:301331) Headlines

No Headlines